UnitedHealth (UNH) closed at $29.08 Friday, near one-year high. UnitedHealth is hosting an investor meeting on December 2. December option implied volatility is at 40; January is at 42; below its 26-week average of 48 according to Track Data, suggesting decreasing price movement.

Semiconductor Holders Trust - SMH overall volatility at 29; 26-week average is 33.

Russell 2000 - IWM overall implied volatility at 27; 26-week average is 33.

Financial Select Sector - XLF overall volatility at 34; 26-week average is 40.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Today was another trading day bare of major economic data. Shares were all over the place today with the indexes not giving any clear direction at any point of the day. It was not until right before the close that you had a real feel for whether we would close up or down today.

Here are the unofficial closing bell levels:

Dow 9,874.31 -11.49 (-0.12%)
S&P 500 1,073.56 -2.63 (-0.24%)
Nasdaq 2,140.22 +1.08 (0.05%)

Top Analyst Upgrades
Top Analyst Downgrades
Top Stock Rumors
Day Trader Alerts

Analyst upgrades:

• Citigroup upgraded Procter & Gamble (NYSE:PG) to Buy from Hold after meeting with management as it believes a more aggressive strategy will lead to the company regaining market share. Citi raised its target on shares to $66 from $54.
  
• Piper Jaffray upgraded Allscripts (NASDAQ:MDRX) to Overweight from Neutral after learning the company signed a large contract with North Shore Long Island Jewish Hospital. Piper now sees upside to estimates and raised its target on shares to $22.50 from $14.
  
• UBS upgraded Amedisys (NASDAQ:AMED) to Buy from Neutral following a review of the Senate Finance Committee's healthcare proposal, which they view as "benign." The firm raised its target to $57 from $46.
• Daimler (NYSE:DAI) was upgraded to Outperform from Market Perform at Bernstein.
  
• Boston Private (NASDAQ:BPFH) was upgraded to Outperform from Market Perform at Keefe Bruyette.
  
• E-Trade (NASDAQ:ETFC) was upgraded to Buy from Neutral at Goldman.

Sanofi-Aventis (NYSE: SNY - option chain) shares are rising today after health insurer Unitedhealth Group (NYSE: UNH) announced that it would fully cover swine flu vaccinations, even for members that do not have immunizations typically covered. As one of the drugmakers that is producing a swine flu vaccine, SNY stands to benefit. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on SNY.

SNY opened this morning at $33.69. So far today the stock has hit a low of $33.63 and a high of $34.17. As of 11:45, SNY is trading at $33.89 up $1.02 (3.1%). The chart for SNY looks neutral and S&P gives SNY a neutral 3 STARS (out of 5) hold ranking.

Unless you've been spending your summer vacation on a tropical beach with no television or internet access, you have seen that the public reception to Congress' proposals for heathcare reform have not exactly been well accepted. I mean, nut jobs showing up to town hall meetings with guns strapped to their legs isn't really the norm.

So you would think that the Republicans who are against a public insurance plan are in control, right? Not so fast.

Congressional Democrats are now talking about splitting the healthcare bills into two parts so they can take advantage of a loophole called reconciliation.

Analyst upgrades:

• B. Riley upgraded Finish Line (NASDAQ: FINL) to Buy from Neutral to reflect the potential for improving trends in second half of 2009. The firm raised its target on shares to $10.50 from $9.
• Merriman upgraded OptionXpress (NASDAQ: OXPS) to Neutral from Sell following the company's better than expected Q2 results. The firm notes higher commissions per trade more than offset weak DARTs and the decline in customer additions in the quarter.
• RBC Capital upgraded Gardner Denver (NYSE: GDI) to Outperform from Sector Perform and raised its target to $34 from $28 citing the additional scale of restructuring, better tone to end-markets, and few downside catalysts. Baird upgraded Gardner Denver to Outperform from Neutral and raised its target to $35 from $32 based on a bottom in fundamentals and compelling valuation.
• BE Aerospace (NASDAQ: BEAV) was upgraded to Outperform from Market Perform at FBR Capital.
• Shire (NASDAQ: SHPGY) was upgraded to Perform from Underperform at Oppenheimer.
• UnitedHealth (NYSE: UNH) was upgraded to Outperform from Neutral at Credit Suisse.

Here are some highlights from last week's earnings coverage from BloggingStocks:

• Amazon.com Inc. (NASDAQ: AMZN) met Q2 earnings estimates but fell short of revenue expectations.
• Coca-Cola Co. (NYSE: KO) lower Q2 results beat expectations, lifted by strength in non-cola beverages.
• Continental Airlines Inc. (NYSE: CAL) reported net loss was accompanied by a job cuts announcement.
• Ford Motor Co. (NYSE: F) surprised with a Q2 profit due mainly to a huge gain from debt reduction.
• Hasbro Inc. (NYSE: HAS) posted better-than-expected Q2 earnings due to Transformers and G.I. Joe toys.
• Hershey Co. (NYSE: HSY) posted strong numbers for Q2 and also raised its full-year guidance.

Today's news boiled down to two issues. First was that five DJIA components reporting earnings this morning, with details on three components. The second issue was Ben Bernanke testifying that inflation was not a huge concern because the economy is likely to stay frail for some time. The markets were mixed to down most of the day until a late day rally saved shares.

Here were today's unofficial closing bell levels:

Dow 8,911.71 +63.56 (0.72%)
S&P 500 954.10 +2.97 (0.31%)
Nasdaq 1,914.13 +4.84 (0.25%)

Top 10 Analyst Upgrades/Downgrades

This was an interesting day in the markets. The market opened higher because of yesterday's recovery, but slid from the open. And it slid lower most of the day. Commodities fell again on worries that the economy isn't far enough along to support higher prices, and possible regulation on the size of speculators continued to hamper prices.

T. Boone Pickens gave bullish oil forecasting today, but compared to the past it wasn't that bullish. There was no major economic data for the markets to chew today, just a continued paring down of expectations ahead of earnings season. Here were the unofficial closing bell levels:

Dow 8,162.39 -162.48 (-1.95%)
S&P 500 880.96 -17.76 (-1.98%)
Nasdaq 1,746.17 -41.23 (-2.31%)

Top Analyst Calls

TheStreet.com's Jim Cramer says the bank has the least to worry about and can gain from new federal regulation.

Sometimes you just have to step back from the small-picture hubbub and make some assumptions about the new landscape if legislation passes.

If you look at the health care legislation you know that it is going to cut out some profitability for companies that have relied on the government for big profits, which means the companies that have the most Medicare exposure. So you go with the health maintenance company with the least Medicare exposure -- WellPoint (NYSE: WLP) (Cramer's Take). It simply can't get hit as badly as a Humana (NYSE: HUM) (Cramer's Take) or a UnitedHealth (NYSE: UNH) (Cramer's Take) because it doesn't have the exposure.

Analyst upgrades:

• Keefe Bruyette upgraded Bank of America (NYSE:BAC) to Outperform from Market Perform due to valuation and the company's better balance sheet following capital raises. The firm raised its target on shares to $16.50.
  
• Merriman upgraded Blue Coat Systems (NASDAQ:BCSI) to Buy from Neutral to reflect stabilizing demand and merger synergies from the Packeteer acquisition.
  
• Thomas Weisel upgraded Genomic Health (NASDAQ:GHDX) to Overweight from Market Weight based on valuation, a new colon cancer assay expected in 2010, and upside from new sales hires.
• Plexus (NASDAQ:PLXS) was upgraded to Outperform from Neutral at Baird.
  
• Great Plains Energy (NYSE:GXP) was raised to Buy from Neutral at Goldman.
  
• Ericsson (nASDAQ:ERIC) was upgraded at Societe Generale to Buy from Hold.

UnitedHealth Group (NYSE: UNH - option chain) stock is falling today after Chairman of the Board Richard T. Burke sold 100,000 shares of the stock on the open market last Friday. That equates to $2.9M of selling against no insider buying in the past two months. If you think this stock won't be rising too far in the coming months, then it could be a good time to look at a bearish hedged play on UNH.

This morning, UNH opened at $27.06. So far today the stock has hit a low of $26.37 and a high of $27.80. As of 11:30, UNH is trading at $26.98, down $0.61 (-2.2%). The chart for UNH looks bullish and S&P gives UNH a positive 4 STARS (out of 5) buy ranking.

Analyst upgrades:

• Jefferies upgraded Home Depot (NYSE: HD) to Buy from Hold as they expect significant multiple expansion as earnings revisions start to bottom out and the market starts to factor in a recovery. The firm raised its price target to $24 from $18-$20.
  
• Goldman upgraded HSBC (NYSE: HBC) to Neutral from Sell and removed the stock from their Asia Pacific Sell List given the company's plans to stop making new loans at its U.S. unit.
  
• Deutsche Bank upgraded Ensco International (NYSE: ESV) to Hold from Sell on valuation as it believes weakening shallow water demand is priced into shares at current levels. The firm raised its target price to $32 from $30.
• Liberty Global (NASDAQ: LBTYA) was raised to Equal Weight from Underweight at Morgan Stanley.
  
• UnitedHealth (NYSE: UNH) was lifted to Outperform from Market Perform at Bernstein.

TheStreet.com's Jim Cramer says if you need money for anything important in the near future, get it out of the stock market.

Fall back. Fall back to basic principles. What do people have to do whether they want to do it or not? What do governments have to pay for whether they want something or not? What must be used whether you like it or not?

That's where we are right now in the helter-skelter pell-mell race to take all stocks to single digits as the notion of a worldwide global depression sinks in.

Humana (NYSE: HUM - option chain) stock is declining today after the company said preliminary 2010 Medicare Advantage payment rates could cause reduced profits in 2010. These comments from HUM are dragging down the entire group, including industry stalwart UnitedHealth Group (NYSE: UNH), which is off by upwards of 15%. If you think this stock won't be rising too far in the coming months, then it could be a good time to look at a bearish hedged play on HUM.

This morning, HUM opened at $36.70. So far today the stock has hit a low of $30.57 and a high of $36.86. As of 11:55, HUM is trading at $31.41, down $9.13 (-22.5%). Prior to today, the chart for HUM looked bullish, while S&P gives HUM a positive 4 STARS (out of 5) buy ranking.